All In Biotech

Drug Trial Radar · NCT01698476

Immune Reconstitution in Tuberculosis Disease

Immune Reconstitution in Tuberculosis Disease Using Antimicrobial Treatment With Vitamin D and Phenylbutyrate

Last checked: Nov 19, 2026Latest source record: Feb 5, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 390 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

390

Actual

Start

Sep 2012

Primary completion

Aug 2015

Study completion Aug 2015

Sponsor

Lead sponsor
Karolinska InstitutetAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Addis Ababa University; Armauer Hansen Research Institute, Ethiopia
First posted
Oct 3, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim with study is to provide adjunctive therapy with vitamin D and phenylbutyrate together with standard anti-tuberculosis treatment to significantly improve clinical recovery among patients with untreated, active pulmonary tuberculosis.

Conditions

  • Pulmonary Tuberculosis (TB)

Interventions

  • vitamin D (cholecalciferol) and PBA (sodium phenylbutyrate)Drug

    Dose of interventions: 5,000 IU of vitamin D (cholecalciferol tablets) once daily and 500 mg PBA (sodium phenylbutyrate tablets) twice daily for 16 weeks.

  • Placebo tabletsDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite clinical TB scoreTime frame: 0 (baseline) compared to 8 weeks.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Black Lion Hospital (BLH), Addis Ababa University, Faculty of Medicine

    Addis Ababa, Lideta sub city, Ethiopia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.